While a population of TIC in glioblastomas can be identified by the glycoprotein CD133, some CD133-negative cells in these tumours have the ability to self-renew, thus this marker may not be indicative of all stem cells within glioblastoma tumours [95]. This evidence concerns the gene PROM1 and neoplasm.